Health Technology · Pharmaceuticals: Major · NSE: BPLPHARMA · data 2026-10-09
Bharat Parenterals Ltd.
Health check: Weak (2.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,864
Market cap
₹1,313 cr
P/E
—
P/B
—
ROE
-2.5%
ROCE
-4.2%
Debt / equity
0.45
Dividend yield
0.05%
1-year return
33.1%
52-week high
₹2,277.6
52-week low
₹1,125.7
Operating margin
-7.4%
Growth
| Revenue (last 12 months) | ₹323 cr |
| Net profit (last 12 months) | ₹-15 cr |
| Sales growth, 3 years (yearly) | 16.5% |
| Profit growth, 3 years (yearly) | — |
Similar companies
Anlon Healthcare Limited (AHCL) · TTK Healthcare Limited (TTKHLTCARE) · Kopran Limited (KOPRAN) · Remus Pharmaceuticals Ltd. (REMUS) · Lincoln Pharmaceuticals Ltd (LINCOLN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BPLPHARMA in NSE Scanner →